Long-term effectiveness and safety of antiepileptic drugs in children and adults
- Authors: Shaimardanova R.M.1, Gamirova R.G.2,3
-
Affiliations:
- A.Yu. Ratner’s Pediatric City Hospital
- Kazan (Volga Region) Federal University
- Kazan State Medical Academy — Branch Campus of the Russian Medical Academy of Continuing Professional Education
- Issue: Vol 19, No 2 (2021)
- Pages: 221-228
- Section: Clinical pharmacology
- Submitted: 05.05.2021
- Accepted: 24.05.2021
- Published: 09.08.2021
- URL: https://journals.eco-vector.com/RCF/article/view/70212
- DOI: https://doi.org/10.17816/RCF192221-228
- ID: 70212
Cite item
Abstract
AIM: To conduct a retrospective comparative analysis of the efficacy and safety of epilepsy therapy with antiepileptic drugs.
MATERIALS AND METHODS: The analysis of the treatment of 428 patients with epilepsy at the Children’s City Hospital No. 8 in Kazan, receiving antiepileptic drugs.
RESULTS: It was found that valproic acid is more effective in the treatment of idiopathic generalized epilepsies compared to focal epilepsies (p = 0.0006). Valproate and carbamazepine were the most effective in the treatment of focal epilepsy with short- and long-term follow-up. Valproic acid is more effective than topiramate (p = 0.02), oxcarbazepine (p = 0.003), and levetiracetam (p = 0.003) in the treatment of focal epilepsy in short- and long-term follow-up. Carbamazepine is more effective than topiramate (p = 0.01), oxcarbazepine (p = 0.02), and levetiracetam (p = 0.001) in the treatment of focal epilepsy in long-term follow-up. It was revealed that more often they complained about side effects when using carbamazepine (63.2%). Levetiracetam was found to be better tolerated compared to valproate (p = 0.0006) and carbamazepine (p = 0.0006). Topiramate is better tolerated than carbamazepine (p = 0.02) and valproate (p = 0.03). Oxcarbazepine is better tolerated than carbamazepine in women (p = 0.04).
CONCLUSIONS: When choosing an antiepileptic drug, it is necessary to be guided by the principle: first the basic, and then the drugs of the next generations, in the future, rely on information about the tolerability of the drug. It is necessary to evaluate the therapeutic effect of antiepileptic drugs with long-term observation, and use the criterion of “complete absence of seizures” as an indicator of the effectiveness of drugs.
Full Text
About the authors
Roza M. Shaimardanova
A.Yu. Ratner’s Pediatric City Hospital
Author for correspondence.
Email: roza.shaimardanova@mail.ru
ORCID iD: 0000-0001-6287-8896
SPIN-code: 8819-3304
neurologist
Russian Federation, 11, Galeeva str., Kazan, 420061Rimma G. Gamirova
Kazan (Volga Region) Federal University; Kazan State Medical Academy — Branch Campus of the Russian Medical Academy of Continuing Professional Education
Email: r-gamirov@mail.ru
ORCID iD: 0000-0002-8582-592X
SPIN-code: 2604-6583
References
- Jones JK, Tilson HH, Lewis JD. Pharmacoepidemiology: defining the field and its core content. Pharmacoepidemiol Drug Saf. 2012;21(7):677–689. doi: 10.1002/pds.3198
- Wise L. Risks and benefits of (pharmaco)epidemiology. Ther Adv Drug Saf. 2011;2(3):95–102. doi: 10.1177/2042098611404920
- Yur’ev KL. Noveishie – tret’ego pokoleniya – protivoehpilepticheskie preparaty. Ukrainskii meditsinskii zhurnal. 2012;(4):90. (In Russ.)
- Andersen M. Research on drug safety and effectiveness using pharmacoepidemiological databases. J Internal Med. 2014;275(6):548–550. doi: 10.1111/joim.12235
- Iyer A, Marson A. Pharmacotherapy of focal epilepsy. Expert Opin Pharmacother. 2014;15(11):1543–1551. doi: 10.1517/14656566.2014.922544
- Bruen BK, Ku L, Burke MF, Buntin MB. More than four in five office-based physicians could qualify for federal electronic health record incentives. Health Aff (Millwood). 2011;30(3):472–480. doi: 10.1377/hlthaff.2010.0932
- Glauser T, Ben-Menachem E, Bourgeois B, et al. ILAE treatment guidelines: Evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes. Epilepsia. 2006;47(7):1094–1120. doi: 10.1111/j.1528-1167.2006.00585.x
- Nevitt SJ, Sudell M, Weston J, et al. Antiepileptic drug monotherapy for epilepsy: a network meta-analysis of individual participant data. Cochrane Database Syst Rev. 2017;(15):12. doi: 10.1002/14651858.CD011412.pub3
- Geng H, Wang C. Efficacy and safety of oxcarbazepine in the treatment of children with epilepsy: a meta-analysis of randomized controlled trials. Neuropsychiatr Dis Treat. 2017;13:685–695. doi: 10.2147/NDT.S130269
- Nicolson A, Appleton RE, Chadwick DW, et al. The relationship between treatment with valproate, lamotrigine, and topiramate and the prognosis of the idiopathic generalized epilepsies. J Neurol Neurosurg Psychiatry. 2004;75:75–79.
- Hu Y, Huang Y, Quan F, et al. Comparison of the retention rates between carbamazepine and valproate as an initial monotherapy in Chinese patients with partial seizures: A ten-year follow-up, observational study. Seizure-Eur J Epilep. 2011;20(3):208–213. doi: 10.1016/j.seizure.2010.11.020
- Bertsche A, Neininger MP, Dahse AJ, et al. Initial anticonvulsant monotherapy in routine care of children and adolescents: levetiracetam fails more frequently than valproate and oxcarbazepine due to a lack of effectiveness. Eur J Pediatr. 2014;173(1):87–92. doi: 10.1007/s00431-013-2125-1
- Zhu F, Lang SY, Wang XQ, et al. Long-term Effectiveness of Antiepileptic Drug Monotherapy in Partial Epileptic Patients: A 7-year Study in an Epilepsy Center in China. Chin Med J (Engl). 2015;128(22):3015–3022. doi: 10.4103/0366-6999.168968
- Nevitt SJ, Sudell M, Tudur Smith C, et al. Topiramate versus carbamazepine monotherapy for epilepsy: an individual participant data review. Cochrane Database Syst Rev. 2019;24:6: CD012065. doi: 10.1002/14651858.CD012065.pub3
- Zeng QY, Fan TT, Zhu P, et al. Comparative Long-Term Effectiveness of a Monotherapy with Five Antiepileptic Drugs for Focal Epilepsy in Adult Patients: A Prospective Cohort Study. PLoS One. 2015;6(10):7: e0131566. doi: 10.1371/journal.pone. 0131566.